✦ LIBER ✦

Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia

✍ Scribed by Fontanelli, Giulia; Rocco, Melania; Caracciolo, Francesco; Benedetti, Edoardo; Buda, Gabriele; Orciuolo, Enrico; Carulli, Giovanni; Galimberti, Sara; Azzarà, Antonio; Petrini, Mario

Book ID: 121420700
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 283 KB
Volume: 14
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and pharmacokinetics of the antis

Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)

✍ Harry P. Erba, Hamid Sayar, Mark Juckett, Michael Lahn, Valerie Andre, Sophie Ca 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 425 KB

Etoposide in combination with low-dose C

Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China

✍ Zhang, Xi; Li, Yunlong; Zhang, Yanqi; Chen, Xinghua; Zhang, Cheng; Gao, Li; Kong 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 962 KB